Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation.


Kidney transplants may be lost due to recurrence of the primary disease. In glomerulonephritis, all kinds taken together, 3% of the patients lose their grafts due to recurrence [1]. If, however, a first kidney graft has been lost from recurrence, the rate of failure caused by recurrence in subsequent grafts is ∼48% [1]. Focal segmental glomerulosclerosis… (More)
DOI: 10.1093/ndt/gfn099


1 Figure or Table

Slides referencing similar topics